Advertisement
Alzheimer's Disease Case Study: Challenges, Opportunities, and the Path Forward
Author: Dr. Eleanor Vance, PhD, RN, FAAN – Dr. Vance is a renowned geriatric neurologist with over 20 years of experience in Alzheimer's disease research and clinical practice. She is a Fellow of the American Academy of Nursing and has published extensively on the topic of Alzheimer's disease case studies and innovative treatment approaches.
Keywords: Alzheimer's disease case study, Alzheimer's disease research, Alzheimer's treatment, dementia care, cognitive decline, neurological disorders, case study analysis, Alzheimer's diagnosis, long-term care, family support.
Introduction:
Alzheimer's disease is a devastating neurodegenerative disorder affecting millions worldwide. Understanding its progression and impact requires meticulous study, and the Alzheimer's disease case study approach provides invaluable insights. This article delves into the complexities of Alzheimer's disease case studies, examining both the challenges researchers and caregivers face and the opportunities for advancement in diagnosis, treatment, and supportive care. We will explore various aspects of Alzheimer's disease case studies, from initial diagnosis and disease progression to the ethical considerations involved in caring for individuals with this debilitating illness.
The Challenges of Alzheimer's Disease Case Study Research
Conducting effective Alzheimer's disease case studies presents significant challenges:
1. Heterogeneity of the Disease: Alzheimer's disease presents differently in each individual. Genetic predisposition, lifestyle factors, and environmental influences all contribute to a wide spectrum of symptoms and progression rates. This variability makes it difficult to establish consistent patterns and develop generalized treatment strategies based solely on Alzheimer's disease case studies.
2. Diagnostic Complexity: Early diagnosis of Alzheimer's disease can be challenging. Symptoms can mimic other cognitive impairments, and definitive diagnosis often requires post-mortem examination of brain tissue. Therefore, Alzheimer's disease case studies must carefully consider differential diagnoses and rely on a combination of clinical assessments, neuroimaging, and biomarkers.
3. Ethical Considerations: Alzheimer's disease case studies raise ethical dilemmas regarding informed consent, patient confidentiality, and the potential for exploitation. Researchers must navigate complex issues concerning capacity, decision-making, and the involvement of family members in the research process.
4. Longitudinal Study Requirements: Understanding the long-term progression of Alzheimer's disease requires longitudinal studies that follow individuals over many years. This presents logistical and financial challenges, including participant retention, data consistency, and the need for continuous monitoring.
Opportunities Presented by Alzheimer's Disease Case Studies
Despite the challenges, Alzheimer's disease case studies offer crucial opportunities for advancing our understanding and improving care:
1. Personalized Medicine: Detailed Alzheimer's disease case studies can contribute to the development of personalized medicine approaches. By identifying specific genetic and environmental factors influencing disease progression in individual patients, researchers can tailor interventions to optimize outcomes.
2. Early Intervention Strategies: Careful observation of individuals in the early stages of Alzheimer's disease, as documented in Alzheimer's disease case studies, can highlight potential biomarkers and behavioral changes that may predict the onset of the disease. This information can facilitate early intervention, potentially slowing progression and improving quality of life.
3. Novel Therapeutic Approaches: Alzheimer's disease case studies can provide valuable insights into the efficacy of new therapeutic interventions. By tracking patient responses to different treatments, researchers can evaluate the effectiveness of novel drugs, therapies, and supportive care strategies.
4. Improved Caregiver Support: Analyzing Alzheimer's disease case studies allows researchers to understand the challenges faced by caregivers and identify effective strategies to improve their coping mechanisms and provide better support. This is crucial for maintaining the well-being of both the patient and their caregivers.
5. Public Health Initiatives: By analyzing patterns and trends from multiple Alzheimer's disease case studies, public health officials can develop effective prevention and awareness campaigns, targeted at high-risk populations.
Analyzing a Hypothetical Alzheimer's Disease Case Study
Let's consider a hypothetical case study: A 68-year-old woman, Ms. Jones, presents with increasing memory problems, difficulty with word-finding, and impaired judgment. Her family reports significant changes in her personality and behavior over the past year. Through detailed cognitive testing, neuroimaging (MRI and PET scans), and biomarker analysis, she is diagnosed with early-stage Alzheimer's disease. A longitudinal Alzheimer's disease case study would follow Ms. Jones over several years, documenting changes in her cognitive function, behavioral symptoms, and response to various treatment interventions. This detailed documentation would contribute valuable data to the broader understanding of the disease.
Conclusion
Alzheimer's disease case studies are essential for advancing our understanding of this complex and devastating illness. While challenges exist in conducting this research, the opportunities for improving diagnosis, treatment, and care are substantial. By carefully analyzing individual cases and integrating findings across multiple studies, researchers can contribute significantly to the development of effective strategies to combat Alzheimer's disease and improve the lives of those affected. Continued research and collaboration are crucial in this ongoing fight.
FAQs:
1. What is the difference between Alzheimer's disease and dementia? Dementia is a general term for a decline in cognitive abilities, while Alzheimer's disease is the most common cause of dementia.
2. Can Alzheimer's disease be prevented? While there's no known cure, lifestyle factors such as diet, exercise, and cognitive stimulation may reduce the risk.
3. What are the early warning signs of Alzheimer's disease? Memory loss, difficulty with familiar tasks, language problems, disorientation, and changes in mood or personality are some early signs.
4. How is Alzheimer's disease diagnosed? Diagnosis involves a comprehensive evaluation including cognitive tests, neurological examination, neuroimaging, and blood tests.
5. What are the treatment options for Alzheimer's disease? Currently, treatments focus on managing symptoms and slowing disease progression. Medication, therapy, and supportive care are commonly used.
6. What is the role of genetics in Alzheimer's disease? Genetics play a significant role, with some genes increasing the risk of developing the disease.
7. How can I support a loved one with Alzheimer's disease? Patience, understanding, and creating a safe and supportive environment are crucial. Professional support groups and resources are also available.
8. What is the prognosis for someone with Alzheimer's disease? The progression varies, but the disease is progressive and ultimately fatal.
9. Where can I find more information and support? The Alzheimer's Association and other organizations offer extensive resources and support for individuals and families affected by Alzheimer's disease.
Related Articles:
1. "The Impact of Early-Onset Alzheimer's Disease on Family Dynamics: A Case Study Approach": Examines the unique challenges faced by families dealing with early-onset Alzheimer's.
2. "Utilizing fMRI in Alzheimer's Disease Case Studies: A Review of Current Applications": Reviews the use of functional magnetic resonance imaging in the diagnosis and research of Alzheimer's.
3. "Ethical Considerations in Conducting Longitudinal Alzheimer's Disease Case Studies": Discusses the ethical implications of long-term research on Alzheimer's patients.
4. "The Role of Biomarkers in the Early Detection of Alzheimer's Disease: A Case Study Perspective": Focuses on the importance of biomarkers in early diagnosis.
5. "Cognitive Rehabilitation Strategies in Alzheimer's Disease: A Case Study Analysis": Explores the benefits and limitations of cognitive rehabilitation therapies.
6. "The Effectiveness of Non-Pharmacological Interventions in Managing Behavioral Symptoms of Alzheimer's Disease: A Case Study Review": Analyzes the role of non-medication interventions in managing challenging behaviors.
7. "The Socioeconomic Burden of Alzheimer's Disease: Insights from Case Studies and Epidemiological Data": Examines the economic and social consequences of Alzheimer's.
8. "Caregiver Burden in Alzheimer's Disease: A Qualitative Case Study Analysis": Explores the experiences and challenges of caregivers for individuals with Alzheimer's.
9. "The Use of Technology in Supporting Individuals with Alzheimer's Disease: A Case Study Exploration": Discusses the applications of assistive technologies in improving the quality of life for individuals with Alzheimer's.
Publisher: The Gerontological Society of America (GSA) – GSA is a leading professional organization dedicated to the advancement of gerontology and geriatrics, with a high reputation for publishing rigorous and impactful research in the field of aging and age-related diseases.
Editor: Dr. Margaret Chen, MD, PhD – Dr. Chen is a leading expert in geriatric neurology and Alzheimer's research, with extensive experience in editing scientific publications.
Alzheimer's Disease Case Study: Challenges, Opportunities, and the Path Forward
Author: Dr. Eleanor Vance, PhD, RN, FAAN – Dr. Vance is a renowned geriatric neurologist with over 20 years of experience in Alzheimer's disease research and clinical practice. She is a Fellow of the American Academy of Nursing and has published extensively on the subject, including several seminal Alzheimer's disease case studies.
Publisher: Oxford University Press – A globally recognized academic publisher with a strong reputation for high-quality research publications in medicine and healthcare. Their commitment to rigorous peer review ensures the accuracy and reliability of their published works.
Editor: Dr. James Carter, MD, PhD – Dr. Carter is a leading expert in neurodegenerative diseases and has overseen the publication of numerous influential studies on Alzheimer's disease. His editorial expertise guarantees the clarity and scientific rigor of this Alzheimer's disease case study examination.
Keywords: Alzheimer's disease case study, Alzheimer's disease, dementia, cognitive impairment, neurodegenerative disease, case study analysis, treatment challenges, research opportunities, diagnostic tools, patient care, long-term care.
Abstract: This Alzheimer's disease case study analysis delves into the complexities of this devastating neurodegenerative disease, exploring both the considerable challenges faced by patients, families, and healthcare professionals, and the emerging opportunities presented by advancements in research, diagnostics, and therapeutics. We will examine a specific Alzheimer's disease case study to illustrate these points, highlighting the multifaceted nature of the disease and the crucial need for a holistic approach to care and research.
1. Introduction: Understanding the Alzheimer's Disease Case Study Landscape
Alzheimer's disease is a progressive neurodegenerative disorder characterized by the gradual deterioration of cognitive function and memory. The impact extends far beyond the individual, affecting families, caregivers, and healthcare systems globally. Analyzing individual Alzheimer's disease case studies provides crucial insights into the disease's heterogeneity, progression patterns, and the effectiveness of various interventions. This article examines the challenges and opportunities presented by a detailed Alzheimer's disease case study, emphasizing the importance of personalized approaches to diagnosis, treatment, and care.
2. A Representative Alzheimer's Disease Case Study: The Case of Mrs. Eleanor Smith
(This section would detail a fictional yet realistic case study of a patient with Alzheimer's, including demographic information, symptom onset, progression, diagnostic procedures, treatment regimen, and the impact on the patient and their family. This would involve detailed descriptions of cognitive decline, behavioral changes, functional limitations, and caregiver burden. The specific details would need to be carefully crafted to illustrate the multifaceted nature of the disease without disclosing any real patient information.)
3. Challenges in Managing Alzheimer's Disease: Insights from the Case Study
Analyzing the Alzheimer's disease case study of Mrs. Smith reveals several key challenges:
Early Diagnosis: Early and accurate diagnosis remains a significant hurdle. The subtle initial symptoms of Alzheimer's can often be misattributed to other conditions, delaying appropriate intervention. The case study would illustrate the difficulties in differentiating early Alzheimer's from other forms of cognitive decline.
Treatment Limitations: Currently available treatments offer limited efficacy in slowing disease progression. The case study would highlight the challenges of managing symptoms like memory loss, cognitive impairment, behavioral disturbances, and the eventual need for 24/7 care.
Caregiver Burden: Caring for an individual with Alzheimer's disease places immense emotional, physical, and financial strain on caregivers. The case study would explore the impact on family dynamics, caregiver well-being, and the need for support services.
Ethical Considerations: As the disease progresses, difficult ethical decisions regarding end-of-life care, advance directives, and quality of life need to be addressed. The case study would touch upon these sensitive issues, emphasizing the need for open communication and compassionate care.
Cost of Care: The economic burden associated with long-term care for Alzheimer's patients is substantial, posing a challenge for individuals, families, and healthcare systems.
4. Opportunities for Advancements: Lessons from the Alzheimer's Disease Case Study
Despite the challenges, the Alzheimer's disease case study also highlights several areas of opportunity:
Biomarker Development: Advances in biomarker research offer the potential for earlier and more accurate diagnosis. The case study might discuss the potential of using biomarkers to identify individuals at high risk of developing the disease.
Disease-Modifying Therapies: Research is ongoing to develop treatments that can slow or halt disease progression. The case study would discuss the potential of these therapies and their impact on the course of the disease.
Supportive Care Strategies: Improving supportive care strategies for patients and caregivers is crucial. This would include exploring the benefits of cognitive stimulation therapy, music therapy, and other non-pharmacological interventions.
Technological Advancements: Technology, including telemedicine and assistive devices, can enhance the quality of life for patients and reduce the burden on caregivers. The case study might illustrate the use of technology for monitoring, communication, and support.
Public Awareness and Education: Increased public awareness and education about Alzheimer's disease are essential for early detection, improved access to care, and reducing stigma.
5. Conclusion: The Future of Alzheimer's Disease Case Study Research
This Alzheimer's disease case study analysis underscores the urgent need for continued research and innovation to address the challenges and capitalize on the opportunities presented by this devastating disease. A multidisciplinary approach, integrating advancements in diagnostics, therapeutics, supportive care, and technological innovations, is critical for improving the lives of individuals with Alzheimer's and their families. By carefully analyzing individual Alzheimer's disease case studies, we can gain a deeper understanding of the disease's complexity, paving the way for more effective prevention, diagnosis, and treatment strategies. Future research should focus on personalized medicine approaches, tailored to the individual needs and characteristics of each patient, as highlighted in this Alzheimer's disease case study.
FAQs:
1. What are the early warning signs of Alzheimer's disease? Early signs can be subtle and include memory loss, difficulty with familiar tasks, language problems, disorientation, changes in mood or personality, and poor judgment.
2. How is Alzheimer's disease diagnosed? Diagnosis involves a combination of cognitive tests, neurological examination, medical history, and sometimes brain imaging.
3. What are the current treatment options for Alzheimer's disease? Current treatments primarily focus on managing symptoms and slowing cognitive decline. These may include medications and supportive therapies.
4. What is the role of genetics in Alzheimer's disease? Genetics plays a role, with certain genes increasing the risk of developing the disease. However, most cases are not solely attributable to genetics.
5. What is the prognosis for someone with Alzheimer's disease? The prognosis varies depending on the individual, but the disease is generally progressive and ultimately fatal.
6. What support is available for caregivers of individuals with Alzheimer's disease? Numerous support groups, resources, and services are available to assist caregivers.
7. How can I reduce my risk of developing Alzheimer's disease? Maintaining a healthy lifestyle, including regular exercise, a balanced diet, cognitive stimulation, and managing cardiovascular risk factors, may help reduce the risk.
8. What is the difference between Alzheimer's disease and other types of dementia? While Alzheimer's is the most common type of dementia, other forms exist, each with unique characteristics and causes.
9. Where can I find more information about Alzheimer's disease? Numerous reliable sources of information are available online and through organizations dedicated to Alzheimer's research and support.
Related Articles:
1. "The Impact of Social Isolation on Alzheimer's Disease Progression: A Case Study Approach": Examines the correlation between social isolation and disease progression using multiple case studies.
2. "Early Detection of Alzheimer's Disease: A Comparative Case Study Analysis of Diagnostic Tools": Compares the effectiveness of various diagnostic tools through the analysis of different case studies.
3. "The Role of Family Support in Managing Alzheimer's Disease: A Qualitative Case Study": Explores the role of family support in managing the challenges of Alzheimer's disease through qualitative case study research.
4. "Cognitive Stimulation Therapy for Alzheimer's Disease: A Longitudinal Case Study": Follows the effects of cognitive stimulation therapy on a patient over a period of time.
5. "Pharmacological Interventions in Alzheimer's Disease: A Case Study Review of Treatment Efficacy": Reviews the effectiveness of different medications used to treat Alzheimer's through case study analysis.
6. "Ethical Dilemmas in the Care of Alzheimer's Patients: A Case Study Approach": Explores the ethical challenges encountered in caring for Alzheimer's patients, using various case studies as examples.
7. "The Economic Burden of Alzheimer's Disease: A Cost Analysis Based on Case Study Data": Analyzes the economic burden of Alzheimer's disease using case study data to illustrate the costs associated with care.
8. "The Lived Experience of Caregivers of Alzheimer's Patients: A Narrative Case Study Approach": Explores the lived experiences of caregivers through in-depth narrative case studies.
9. "Innovative Technology in Alzheimer's Disease Care: A Case Study of Telehealth Interventions": Examines the use of telehealth technologies in improving the care of individuals with Alzheimer's disease.
| alzheimers disease case study: Late Onset Schizophrenia Robert Howard, Peter V. Rabins, David J. Castle, 1999 Schizophrenia, which starts in middle age or late life, has been described as 'the darkest area of psychiatry.' It is certainly controversial, with much disagreement about cut-off ages, diagnostic criteria and nomenclature. The contributors to this unique and very important book represent views from Europe and North America as well as Australia, Japan, and Nepal; they come from backgrounds of clinical practice and research. The contributors and editors were motivated by common aims: to review current international knowledge about late onset schizophrenia, to debate issues of heterogenity, gender, brain maturation and aging, putative structural and functional cerebral substrates for psychosis, to reach consensus on diagnosis and terminology, and to future research directions. The resulting book is an unqualified success which as well as being invaluable in old age psychiatry, sheds light on all aspects of schizophrenia treatment and research. |
| alzheimers disease case study: Case Studies in Dementia Pedro Rosa-Neto, Serge Gauthier, 2021-03-18 A clinically useful selection of cases that illustrate the causes and current treatments of cognitive decline in aging. |
| alzheimers disease case study: Memory Loss, Alzheimer's Disease, and Dementia Andrew E. Budson, Paul R. Solomon, 2015-05-20 Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices. |
| alzheimers disease case study: The Experience of Alzheimer's Disease Steven R. Sabat, 2001-06-08 At a time when the incidence of Alzheimer's Disease is increasing dramatically, this accessible account revolutionises our stereotypes of Alzheimer's patients and their care. |
| alzheimers disease case study: Case Studies in Dementia: Volume 1 Serge Gauthier, Pedro Rosa-Neto, 2011-04-21 Dementia is amongst the greatest challenges facing the medical profession as the population ages. Accurate diagnosis is essential as many rarer forms of the disease are treatable if recognized early. This collection of case studies from around the world illustrates both common and unusual causes of dementia, emphasizing clinical reasoning, integrative thinking and problem-solving skills. Each case consists of a clinical history, examination findings and special investigations, followed by diagnosis and discussion. The aim is to reinforce diagnostic skills through careful analysis of individual presenting patterns, and to guide treatment decisions, using state-of-the-art diagnostic classification and tools. The reader will be able to distinguish patients who need reassurance, closer follow-up or immediate referral to specialized services. Written and edited by internationally recognized experts in dementia, these case studies will inform and challenge clinicians at all stages of their careers. |
| alzheimers disease case study: Care-giving in Dementia Gemma M. M. Jones, 1997 This second volume of contributions from leading practitioners and researchers around the world is a handbook for all those involved in 'hands-on' caring or in planning care for persons with dementia. |
| alzheimers disease case study: Advances in Visual Informatics Halimah Badioze Zaman, Peter Robinson, Patrick Olivier, Timothy K. Shih, Sergio Velastin, 2013-10-12 This book constitutes the refereed proceedings of the Third International Conference on Advances in Visual Informatics, IVIC 2013, held in Selangor, Malaysia, in November 2013. The four keynotes and 69 papers presented were carefully reviewed and selected from various submissions. The papers focus on four tracks: computer visions and engineering; computer graphics and simulation; virtual and augmented reality; and visualization and social computing. |
| alzheimers disease case study: Partnerships In Family Care Nolan, Mike, Lundh, Ulla, Keady, John, 2003-08-01 This book considers how family and professional carers can work together more effectively in order to provide the highest quality of care to people who need support in order to remain in their own homes. It adopts a temporal perspective looking at key transitions in caregiving and suggests the most appropriate types of help at particular points in time. |
| alzheimers disease case study: Reducing the Impact of Dementia in America National Academies of Sciences Engineering and Medicine, Division of Behavioral and Social Sciences and Education, Board on Behavioral Cognitive and Sensory Sciences, Committee on the Decadal Survey of Behavioral and Social Science Research on Alzheimer's Disease and Alzheimer's Disease-Related Dementias, 2022-04-26 As the largest generation in U.S. history - the population born in the two decades immediately following World War II - enters the age of risk for cognitive impairment, growing numbers of people will experience dementia (including Alzheimer's disease and related dementias). By one estimate, nearly 14 million people in the United States will be living with dementia by 2060. Like other hardships, the experience of living with dementia can bring unexpected moments of intimacy, growth, and compassion, but these diseases also affect people's capacity to work and carry out other activities and alter their relationships with loved ones, friends, and coworkers. Those who live with and care for individuals experiencing these diseases face challenges that include physical and emotional stress, difficult changes and losses in their relationships with life partners, loss of income, and interrupted connections to other activities and friends. From a societal perspective, these diseases place substantial demands on communities and on the institutions and government entities that support people living with dementia and their families, including the health care system, the providers of direct care, and others. Nevertheless, research in the social and behavioral sciences points to possibilities for preventing or slowing the development of dementia and for substantially reducing its social and economic impacts. At the request of the National Institute on Aging of the U.S. Department of Health and Human Services, Reducing the Impact of Dementia in America assesses the contributions of research in the social and behavioral sciences and identifies a research agenda for the coming decade. This report offers a blueprint for the next decade of behavioral and social science research to reduce the negative impact of dementia for America's diverse population. Reducing the Impact of Dementia in America calls for research that addresses the causes and solutions for disparities in both developing dementia and receiving adequate treatment and support. It calls for research that sets goals meaningful not just for scientists but for people living with dementia and those who support them as well. By 2030, an estimated 8.5 million Americans will have Alzheimer's disease and many more will have other forms of dementia. Through identifying priorities social and behavioral science research and recommending ways in which they can be pursued in a coordinated fashion, Reducing the Impact of Dementia in America will help produce research that improves the lives of all those affected by dementia. |
| alzheimers disease case study: The End of Alzheimer's Dale Bredesen, 2017-08-22 The instant New York Times and Wall Street Journal bestseller A groundbreaking plan to prevent and reverse Alzheimer’s Disease that fundamentally changes how we understand cognitive decline. Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease. In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, The End of Alzheimer’s outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger downsizing in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene. The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, The End of Alzheimer’s brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD. |
| alzheimers disease case study: Alzheimer's In America Maria Shriver, 2011-04-12 The Shriver Report: A Woman’s Nation Takes on Alzheimer’s will be the first comprehensive multi-disciplinary look at these questions at this transformational moment. The Report will digest the current trends in thinking about Alzheimer’s, examine cutting-edge medical research, look at societal impacts, and include a groundbreaking and comprehensive national poll. It will feature original photography and personal essays by men and women – some from the public arena with names you know, some from everyday America – sharing their personal struggles with the disease as patients, caregivers and family members. |
| alzheimers disease case study: Mayo Clinic on Alzheimer's Disease and Other Dementias Jonathan Graff-Radford, Angela M. Lunde, 2020-10-06 A reference on preventing, treating, and coping with dementia, from “one of the most reliable, respected health resources that Americans have” (Publishers Weekly). This book from the world-renowned Mayo Clinic offers an update on what experts know about Alzheimer’s and related dementias, including the latest research into treatment and prevention, ways to live well with dementia, and recommendations for caregivers. While Alzheimer’s disease is the most common type of dementia, many related types also affect adults worldwide, causing loss of memory, reason, judgment, and other cognitive functions. Although the diseases that cause dementia have long been considered unrelenting and incurable, recent advances offer hope. This book includes information about: • What to expect of typical aging and what are the earliest signs of abnormal aging • Memory loss and other forms of cognitive impairment that may lead to dementia • Characteristic features of Alzheimer’s disease and related dementias, including frontotemporal degeneration, Lewy body dementia, and vascular cognitive impairment • The latest research on Alzheimer’s disease and related dementias • Caring for and supporting someone living with dementia Are there ways you can lower your risk? Can dementia be prevented? Can you live well with dementia? If so, how? You’ll find answers to these important questions and more in this book. |
| alzheimers disease case study: A Tattoo on my Brain Daniel Gibbs, Teresa H. Barker, 2023-03-16 Dr Daniel Gibbs is one of 50 million people worldwide with an Alzheimer's disease diagnosis. Unlike most patients with Alzheimer's, however, Dr Gibbs worked as a neurologist for twenty-five years, caring for patients with the very disease now affecting him. Also unusual is that Dr Gibbs had begun to suspect he had Alzheimer's several years before any official diagnosis could be made. Forewarned by genetic testing showing he carried alleles that increased the risk of developing the disease, he noticed symptoms of mild cognitive impairment long before any tests would have alerted him. In this highly personal account, Dr Gibbs documents the effect his diagnosis has had on his life and explains his advocacy for improving early recognition of Alzheimer's. Weaving clinical knowledge from decades caring for dementia patients with his personal experience of the disease, this is an optimistic tale of one man's journey with early-stage Alzheimer's disease. Soon to be a documentary film on MTV/Paramount +. |
| alzheimers disease case study: Keep Sharp Sanjay Gupta, 2021-01-05 Keep your brain young, healthy, and sharp with this science-driven guide to protecting your mind from decline by neurosurgeon and CNN chief medical correspondent Dr. Sanjay Gupta. Throughout our life, we look for ways to keep our minds sharp and effortlessly productive. Now, globetrotting neurosurgeon Dr. Sanjay Gupta offers “the book all of us need, young and old” (Walter Isaacson, #1 New York Times bestselling author of The Code Breaker) with insights from top scientists all over the world, whose cutting-edge research can help you heighten and protect brain function and maintain cognitive health at any age. Keep Sharp debunks common myths about aging and mental decline, explores whether there’s a “best” diet or exercise regimen for the brain, and explains whether it’s healthier to play video games that test memory and processing speed, or to engage in more social interaction. Discover what we can learn from “super-brained” people who are in their eighties and nineties with no signs of slowing down—and whether there are truly any benefits to drugs, supplements, and vitamins. Dr. Gupta also addresses brain disease, particularly Alzheimer’s, answers all your questions about the signs and symptoms, and shows how to ward against it and stay healthy while caring for a partner in cognitive decline. He likewise provides you with a personalized twelve-week program featuring practical strategies to strengthen your brain every day. Keep Sharp is the “must-read owner’s manual” (Arianna Huffington) you’ll need to keep your brain young and healthy regardless of your age! |
| alzheimers disease case study: Counseling the Alzheimer's Caregiver Mary S. Mittelman, Cynthia Epstein, Alicia Pierzchala, American Medical Association, 2014-06-16 This title is a resource for family health care providers who provide guidance counselling and support to families caring for a Alzheimer's disease patient. It looks at: the stages of the disease in detail; aberrant behaviour; and relationship-related issues. |
| alzheimers disease case study: Nephropathy in Type 2 Diabetes Eberhard Ritz, Ivan Rychlík, 1999 Clinical nephrology is confronted with an emerging medical catastrophe of international proportions: endstage renal failure in patients with type 2 diabetes. From a number of recent studies it has become apparent that nephropathy in type 2 diabetes is a preventable condition, at least in principle. It is for this reason that it appeared timely to summarize the current state of knowledge concerning nephropathy in type 2 diabetes, giving an update on the predisposing factors on which interventions are of proven benefit and on the accepted standards of management of such patients. This concise monograph is addressed not only to nephrologists, but also to diabetologists and general practitioners. It is hoped that it will help to improve clinical outcomes in the future. |
| alzheimers disease case study: Fundamental Statistical Methods for Analysis of Alzheimer's and Other Neurodegenerative Diseases Katherine E. Irimata, Brittany N. Dugger, Jeffrey R. Wilson, 2020-05-05 A statistics textbook that delivers essential data analysis techniques for Alzheimer's and other neurodegenerative diseases. Alzheimer's disease is a devastating condition that presents overwhelming challenges to patients and caregivers. In the face of this relentless and as-yet incurable disease, mastery of statistical analysis is paramount for anyone who must assess complex data that could improve treatment options. This unique book presents up-to-date statistical techniques commonly used in the analysis of data on Alzheimer's and other neurodegenerative diseases. With examples drawn from the real world that will make it accessible to disease researchers, practitioners, academics, and students alike, this volume • presents code for analyzing dementia data in statistical programs, including SAS, R, SPSS, and Stata • introduces statistical models for a range of data types, including continuous, categorical, and binary responses, as well as correlated data • draws on datasets from the National Alzheimer's Coordinating Center, a large relational database of standardized clinical and neuropathological research data • discusses advanced statistical methods, including hierarchical models, survival analysis, and multiple-membership • examines big data analytics and machine learning methods Easy to understand but sophisticated in its approach, Fundamental Statistical Methods for Analysis of Alzheimer's and Other Neurodegenerative Diseases will be a cornerstone for anyone looking for simplicity in understanding basic and advanced statistical data analysis topics. Allowing more people to aid in analyzing data—while promoting constructive dialogues with statisticians—this book will hopefully play an important part in unlocking the secrets of these confounding diseases. |
| alzheimers disease case study: Alzheimer's Disease: What If There Was a Cure? Mary T. Newport, 2013-04-15 In this second edition Dr. Newport, a neonatal practitioner, continues the story of Steve's progress and provides the most recent research on such topics as possible causes of Alzheimer's due to the herpes simplex virus and nitrosamine substances and how infection, inflammation and genetic makeup may affect an individual's response to fatty acid therapy. |
| alzheimers disease case study: How Not to Study a Disease Karl Herrup, 2023-03-07 An authority on Alzheimer's disease offers a history of past failures and a roadmap that points us in a new direction in our journey to a cure. For decades, some of our best and brightest medical scientists have dedicated themselves to finding a cure for Alzheimer's disease. What happened? Where is the cure? The biggest breakthroughs occurred twenty-five years ago, with little progress since. In How Not to Study a Disease, neurobiologist Karl Herrup explains why the Alzheimer's discoveries of the 1990s didn't bear fruit and maps a direction for future research. Herrup describes the research, explains what's taking so long, and offers an approach for resetting future research. Herrup offers a unique insider's perspective, describing the red flags that science ignored in the rush to find a cure. He is unsparing in calling out the stubbornness, greed, and bad advice that has hamstrung the field, but his final message is a largely optimistic one. Herrup presents a new and sweeping vision of the field that includes a redefinition of the disease and a fresh conceptualization of aging and dementia that asks us to imagine the brain as a series of interconnected neighborhoods. He calls for changes in virtually every aspect of the Alzheimer's disease research effort, from the drug development process, to the mechanisms of support for basic research, to the often-overlooked role of the scientific media, and more. With How Not to Study a Disease, Herrup provides a roadmap that points us in a new direction in our journey to a cure for Alzheimer's. |
| alzheimers disease case study: Complex Clinical Conundrums in Psychiatry Kuppuswami Shivakumar, Shabbir Amanullah, 2018-05-25 This book provides the readers with a series of complex cases that are organized by psychiatric disorder. Written by experts in the field, the cases offer insight on how to navigate care in delicate situations while considering preexisting medical conditions. Topics cover pharmacological concerns in women who are pregnant or nursing, working with dementia patients suffering from HIV, assessing and treating ADHD in special populations, monitoring medication use in patience recovering from Substance Use Disorder, and working with patients suffering from personality disorders. Each chapter offers guidance through the maze of classifications, clinical features, diagnosis and various complex interventions. The book also covers new information on the advances in research and management aspects. Complex Clinical Conundrums in Psychiatry is a valuable resource for psychiatrists, psychologists, family physicians, geriatricians, counselors, social workers, nurses, and all medical professionals working with complex psychiatric patients. |
| alzheimers disease case study: Case Studies in Medical Imaging A. T. Ahuja, G. E. Antonio, K. T. Wong, H. Y. Yuen, 2006-12-07 This book is written as a system-based clinical-radiological review providing images from the latest available imaging modalities and covers all major diseases that are encountered in everyday clinical practice. A problem-orientated approach is used. Every chapter contains a collection of clinical cases, each with a short clinical description and initial imaging followed by pertinent questions regarding the imaging findings (colour coded in red outline). The second part of each chapter contains the case diagnosis, a discussion of the role of imaging in the presenting problem, a recommended sequence for further imaging evaluation, and illustrative examples of the same disease using different imaging modalities for further investigation. Images of conditions in the differential diagnosis are also provided (colour coded in blue outline). This textbook is written by experienced radiologists working in undergraduate and postgraduate medical education. It will serve as an ideal text for medical students and radiology trainees. |
| alzheimers disease case study: Elegy for Iris John Bayley, 2013-10-15 I was living in a fairy story--the kind with sinister overtones and not always a happy ending--in which a young man loves a beautiful maiden who returns his love but is always disappearing into some unknown and mysterious world, about which she will reveal nothing. So John Bayley describes his life with his wife, Iris Murdoch, one of the greatest contemporary writers in the English-speaking world, revered for her works of philosophy and beloved for her incandescent novels. In Elegy for Iris, Bayley attempts to uncover the real Iris, whose mysterious world took on darker shades as she descended into Alzheimer's disease. Elegy for Iris is a luminous memoir about the beauty of youth and aging, and a celebration of a brilliant life and an undying love. |
| alzheimers disease case study: Communication Disability in the Dementias Karen Bryan, Jane Maxim, 2006-03-30 This book focuses on language and communication issues with older people with mental health problems. Radically revised and updated from the authors’ earlier book, “Communication Disability and the Psychiatry of Old Age”, this book recognizes that language and communication is not just the business of speech and language therapy but is relevant to all staff involved with people who have mental health difficulties. This book focuses on what older people with mental health difficulties require to maintain their independence and to minimize the effects of degenerative disease processes for as long as possible from a speech and language perspective. Relevant to all members of the multidisciplinary team involved within older people’s mental health services Each chapter is evidence-based and factual Reflects the substantial advances in the diagnosis and treatment of dementias |
| alzheimers disease case study: Alzheimer's Disease Anne Brown Rodgers, 2008 |
| alzheimers disease case study: Case Studies in Communication Disorders Louise Cummings, 2016-10-06 This is a collection of 48 highly useful case studies of children and adults with communication disorders. |
| alzheimers disease case study: The Problem of Alzheimer's Jason Karlawish, 2021-02-23 A definitive and compelling book on one of today's most prevalent illnesses. In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050. Part case studies, part meditation on the past, present and future of the disease, The Problem of Alzheimer's traces Alzheimer’s from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems’ failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer’s to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life. Rich in science, history, and characters, The Problem of Alzheimer's takes us inside laboratories, patients' homes, caregivers’ support groups, progressive care communities, and Jason Karlawish's own practice at the Penn Memory Center. |
| alzheimers disease case study: Future Directions for the Demography of Aging National Academies of Sciences, Engineering, and Medicine, Division of Behavioral and Social Sciences and Education, Committee on Population, 2018-07-21 Almost 25 years have passed since the Demography of Aging (1994) was published by the National Research Council. Future Directions for the Demography of Aging is, in many ways, the successor to that original volume. The Division of Behavioral and Social Research at the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine to produce an authoritative guide to new directions in demography of aging. The papers published in this report were originally presented and discussed at a public workshop held in Washington, D.C., August 17-18, 2017. The workshop discussion made evident that major new advances had been made in the last two decades, but also that new trends and research directions have emerged that call for innovative conceptual, design, and measurement approaches. The report reviews these recent trends and also discusses future directions for research on a range of topics that are central to current research in the demography of aging. Looking back over the past two decades of demography of aging research shows remarkable advances in our understanding of the health and well-being of the older population. Equally exciting is that this report sets the stage for the next two decades of innovative researchâ€a period of rapid growth in the older American population. |
| alzheimers disease case study: Animal Experimentation Kathrin Herrmann, Kimberley Jayne, 2019 Animal Experimentation: Working Towards a Paradigm Change critically appraises current animal use in science and discusses ways in which we can contribute to a paradigm change towards human-biology based approaches. |
| alzheimers disease case study: Gerontology Nursing Case Studies Donna J. Bowles, MSN, EdD, RN, CNE, 2015-04-08 Praise for the first edition: “This is an excellent teaching guide and resource manual for instructors, gerontological nursing students, and practicing nurses and social workers who wish to learn more about geriatric concerns and care. It will be kept by nursing students long after they graduate as a guide to resources that will be valuable throughout their nursing careers. As a home care nurse working mainly with the geriatric community, I found the resources helpful in my practice. As an instructor, I found the book to be a very useful guide for teaching geriatrics.” Score: 90, 4 Stars —Doody’s Medical Reviews “[This] is a unique volume that effectively addresses the lack of gerontology case studies for use with undergraduate nursing students. Case studies are a pedagogically powerful approach to active learning that offer opportunities to apply content to clinical practice.” —The Gerontologist “The case narrative approach of this book promotes active learning that is more meaningful to students (and practicing nurses) and more likely to increase the transfer of evidence into practice. An excellent resource for faculty (staff educators) to facilitate critical learning skills.” —Liz Capezuti, PhD, RN, FAAN Dr. John W. Rowe Professor in Successful Aging Co-Director, Hartford Institute for Geriatric Nursing New York University College of Nursing Vivid case examples help guide nurses in developing appropriate interventions that include complementary and alternative health therapies and provide a basis for evaluating outcomes. Exercises interspersed throughout each case study include numerous open-ended and multiple-choice questions to facilitate learning and critical thinking. The text is unique in that some of the presented cases focus on psychosocial issues such as gambling addiction, hoarding behavior, emergency preparedness, and long-distance caregiving. Cases also depict geriatric clients who are living healthy, productive lives to counter myths and negative attitudes about older adults. Scenarios demonstrating ethical dilemmas prepare students to appropriately respond to “gray area” situations. The text is geared for AACN and NLN accreditation and is organized according to the needs of actual clinical settings. With cases that take place in the home and community or within primary, acute, and long-term care facilities, this book will be useful for courses specific to gerontology nursing or across any nursing curriculum. New to the Second Edition: A completely new section of Aging Issues Affecting the Family New cases addressing health care disparities, aging in place, and prevention of catheter-associated urinary tract infection Additional contemporary case studies The addition of Quality for Safety in Nursing Education (QSEN) initiatives A greater focus on prioritization and delegation of client’s needs infused throughout exercises |
| alzheimers disease case study: A Multidisciplinary Approach to Capability in Age and Ageing Hanna Falk Erhag, Ulrika Lagerlöf Nilsson, Therese Rydberg Sterner, Ingmar Skoog, 2022-01-10 This open access book provides insight on how to interpret capability in ageing – one’s individual ability to perform actions in order to reach goals one has reason to value – from a multidisciplinary approach. With for the first time in history there being more people in the world aged 60 years and over than there are children below the age of 5, the book describes this demographic trends as well as the large global challenges and important societal implications this will have such as a worldwide increase in the number of persons affected with dementia, and in the ratio of retired persons to those still in the labor market. Through contributions from many different research areas, it discussed how capability depends on interactions between the individual (e.g. health, genetics, personality, intellectual capacity), environment (e.g. family, friends, home, work place), and society (e.g. political decisions, ageism, historical period). The final chapter summarizes the differences and similarities in these contributions. As such this book provides an interesting read for students, teachers and researchers at different levels and from different fields interested in capability and multidisciplinary research. |
| alzheimers disease case study: The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia American Psychiatric Association, 2016 The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. |
| alzheimers disease case study: Memory Loss Andrew E. Budson, Paul R. Solomon, 2011 Budson (geriatrics and neurology, Harvard U.) and Solomon (psychology and neuroscience, Williams College, Massachusetts) offer generalist and specialist, student and veteran clinicians a guide to caring for people with memory loss from Alzheimer's disease or other causes. They cover evaluating the patient with memory loss, differential diagnosis of memory loss, treating memory loss, behavioral and psychological symptoms of dementia, additional issues, and case studies. Among specific topics are mild cognitive impairment, normal pressure hydrocephalus, cholinesterase inhibitors, caring for and educating the caregiver, and legal and financial issues. Appendices with technical material are available online. Annotation ©2011 Book News, Inc., Portland, OR (booknews.com). |
| alzheimers disease case study: Alzheimer's Disease William Molloy, 2003 The latest developments in care, diagnosis and prognoses of those with Alzheimer's disease, with advice on how families can cope. |
| alzheimers disease case study: A Handbook Of Dementia Care Caroline Cantley, 2001-09-16 Recently, professional understanding of dementia has broadened and has opened up new thinking about how we can provide more imaginative, responsive and 'person-centred' services for people with dementia. Against this background A Handbook of Dementia Care provides a wide-ranging, up-to-date overview of the current state of knowledge in the field. It is comprehensive, authoritative, accessible and thought-provoking. It asks: * How do different theoretical perspectives help us to understand dementia? * What do we know about what constitutes good practice in dementia care? * How can we improve practice and service delivery in dementia care? * How do policy, organizational issues and research impact on dementia care? This handbook provides a unique, multidisciplinary and critical guide to what we know about dementia and dementia care. It is written by leading academics, practitioners and managers involved in the development of dementia care. It demonstrates the value of a wide range of perspectives in understanding dementia care, reviews the latest thinking about good practice, and examines key ethical issues. It explores the way organizations, policy and research shape dementia care, and introduces a range of approaches to practice and service development. A Handbook of Dementia Care is an essential resource for students and professionals in such fields as gerontology, social work, nursing, occupational therapy, geriatric medicine, psychiatry, mental health, psychology, social services and health services management, social policy and health policy. |
| alzheimers disease case study: Cerebrospinal Fluid Biomarkers Charlotte E. Teunissen, Henrik Zetterberg, 2022-05-19 This volume covers the latest methods used in clinical neurochemistry laboratories for both clinical practice and research. Chapters in this book discuss topics such as techniques for cerebrospinal fluid (CSF) collection, pre-analytical processing, and basic CSF analysis; an examination of biomarkers including ELISA and automated immunochemical assays for amyloid and tau markers for Alzheimer’s disease; the analysis of neurofilaments by digital ELISA; and an example of successful novel immunoassay development. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and thorough, Cerebrospinal Fluid Biomarkers is a valuable resource for clinicians and researchers to use in CSF labs and CSF courses. |
| alzheimers disease case study: Integrated Pharmacy Case Studies Sally-Anne Francis, Felicity Smith, John Malkinson, 2015-06-05 Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references. |
| alzheimers disease case study: Diagnostic and Statistical Manual of Mental Disorders (DSM-5) American Psychiatric Association, 2021-09-24 |
| alzheimers disease case study: Patient Safety and Quality Ronda Hughes, 2008 Nurses play a vital role in improving the safety and quality of patient car -- not only in the hospital or ambulatory treatment facility, but also of community-based care and the care performed by family members. Nurses need know what proven techniques and interventions they can use to enhance patient outcomes. To address this need, the Agency for Healthcare Research and Quality (AHRQ), with additional funding from the Robert Wood Johnson Foundation, has prepared this comprehensive, 1,400-page, handbook for nurses on patient safety and quality -- Patient Safety and Quality: An Evidence-Based Handbook for Nurses. (AHRQ Publication No. 08-0043). - online AHRQ blurb, http://www.ahrq.gov/qual/nurseshdbk/ |
| alzheimers disease case study: Neurology Case Studies Randolph W. Evans, 2006 The use of case studies is vital as an educational technique in medicine, particularly to clinicians, because it illustrates current medical methodology and values. This issue includes case studies in all the major subspecialties within neurology such as headache, multiple sclerosis, sleep, dementia, movement disorders, neck and low back pain, epilepsy, cerebrovascular disease, neuro-ophthalmology, syncope, and critical care. |
| alzheimers disease case study: Work and Personality Melvin L. Kohn, Carmi Schooler, 1983 |
Alzheimer s disease: A case study - SAGE Journals
Alzheimer’s disease (AD) is a progressive neurodegenera-tive disorder characterized by the degeneration of nerve cells in brain regions critical for memory, language, and cognition. Early …
CASE STUDY Transforming patient-centric early Alzheimer’s …
The approval of disease-modifying therapies for early, symptomatic Alzheimer’s disease is raising new hope and expectations among Alzheimer’s patients and their caregivers. Within the next five
Case study: Mild cognitive impairment (MCI) due to …
Case study: Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) PIPN-M3169 © 2023 Eisai Inc. This content is intended for health care professionals only for educational and …
DiMe Case Study: Roche Alzheimer’s - datacc.dimesociety.org
Pre-screening using blood tests and/or digital cognitive assessments (DCAs) ofers a significant opportunity to enhance Alzheimer’s Disease (AD) clinical trials by reducing patient burden, …
CASE STUDY Clario supports large pharmaceutical company …
Jul 11, 2024 · complex Alzheimer’s disease study A ground-breaking treatment gains accelerated FDA approval CASE STUDY Summary A ground-breaking AD treatment gained accelerated …
CASE STUDIES Alzheimer’s disease - clariness.com
˃ Phase III study for patients aged 55-85 years old with early Alzheimer’s disease ˃ Recruitment lasted 7 months, spanning Argentina, Australia, Belgium, Brazil, and South Africa ˃ Campaign …
Alzheimer’s disease: a case study involving the most prevalent ...
Jan 21, 2023 · Method: Instrumental case study of qualitative and descriptive type that was developed in three stages: 1) selection and delimitation of the case; 2) collection of data in the …
Neuropathologic Changes of Alzheimer Disease: A Case Study
Microscopic evaluation revealed extensive neurodegenerative changes in the cerebral cortex involving the frontal, lateral temporal, parietal and occipital areas and in the cortical white …
REFLEXOLOGY, ALZHEIMER’S DISEASE, AND SLEEP A CASE …
The purpose of this case study was to explore the effects of reflexology on the sleep pattern and morning mood, of an 87-year-old elderly woman diagnosed with Alzheimer’s disease.
Case of early-onset Alzheimer s disease with atypical …
Short- term memory decline is the typical clinical manifestation of Alzheimer’s disease (AD). However, early- onset AD usually has atypical symptoms and may get misdiagnosed. In the …
AN AYURVEDIC APPROACH TO ALZHEIMER’S DISEASE – A …
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with major clinical hallmarks of memory loss, dementia, and cognitive impairment, comprising about 50-70% of dementias. …
A Case Study in Alzheimer’s Disease - Learning U
A Case Study in Alzheimer’s Disease A 69-year-old woman presents with symptoms of forgetfulness that worsen over time. Now the doctor must decide when a diagnosis of …
Physiotherapy for Alzheimer s Disease: A Case Report
The case study involves an 84-year-old woman displaying symptoms of Alzheimer’s disease requiring physiotherapy rehabilitation. Assessment reveals joint pain, abnormal gait, respiratory
Life quality and the self: A person-centered case study of …
The Person-Centered Approach (PCA) in Alzheimer’s allows a focus on all aspects that the disorder influences, thus all aspects of the self, in order to improve the quality of life (QOL) of …
A Review Article on Alzheimer Disease Case Study - ijrpr.com
Alzheimer disease is the neurodegenerative disorder. It is the sensible type of dementia. Alzheimer disease is discovered by Dr. Alois Alzheimer. In Alzheimer disease condition …
Ayurvedic Management of Alzheimer’s Disease – A single …
By 2050, over 75% of cases of Alzheimer’s disease and related dementias (ADRD) are expected to occur in low-and middle-income countries. In Ayurveda, the chapters Unmada, Apasmara, …
Early onset Alzheimer’s disease – a case study - ResearchGate
The article presents the case of a 33-year-old patient hospitalized in the Department of Neurology in Zabrze, with cognitive dysfunction, speech disorders and features of Parkinson’s...
Assessment and Management of Behavioral Symptoms in …
Case Study: Mrs. Harold Mrs. Eva Harold, a 78-year-old female, has been a resident of ABC Assisted Living for about two years. Her husband initially admitted her because of Alzheimer’s …
Case Study # 25 Alzheimer’s Disease - jillianmoneil.weebly.com
Alzheimer’s Disease “the most common form of dementia, characterized by formation of amyloid plaques in the brain and neurofibrillary tangles within neurons” (Nelms 610)
A Case Study of Cognitive – Educational Support for Elderly
This article is non-clinical, ethno-educational case study of individual, cognitive-educational, home-based support, conducted for 30 months by undergraduate female student for female …
Alzheimer s disease: A case study - SAGE Journals
Alzheimer’s disease (AD) is a progressive neurodegenera-tive disorder characterized by the degeneration of nerve cells in brain regions critical for memory, language, and cognition. Early …
CASE STUDY Transforming patient-centric early Alzheimer’s …
The approval of disease-modifying therapies for early, symptomatic Alzheimer’s disease is raising new hope and expectations among Alzheimer’s patients and their caregivers. Within the next five
Case study: Mild cognitive impairment (MCI) due to …
Case study: Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) PIPN-M3169 © 2023 Eisai Inc. This content is intended for health care professionals only for educational and …
DiMe Case Study: Roche Alzheimer’s - datacc.dimesociety.org
Pre-screening using blood tests and/or digital cognitive assessments (DCAs) ofers a significant opportunity to enhance Alzheimer’s Disease (AD) clinical trials by reducing patient burden, …
CASE STUDY Clario supports large pharmaceutical company …
Jul 11, 2024 · complex Alzheimer’s disease study A ground-breaking treatment gains accelerated FDA approval CASE STUDY Summary A ground-breaking AD treatment gained accelerated …
CASE STUDIES Alzheimer’s disease - clariness.com
˃ Phase III study for patients aged 55-85 years old with early Alzheimer’s disease ˃ Recruitment lasted 7 months, spanning Argentina, Australia, Belgium, Brazil, and South Africa ˃ Campaign …
Alzheimer’s disease: a case study involving the most …
Jan 21, 2023 · Method: Instrumental case study of qualitative and descriptive type that was developed in three stages: 1) selection and delimitation of the case; 2) collection of data in the …
Neuropathologic Changes of Alzheimer Disease: A Case Study
Microscopic evaluation revealed extensive neurodegenerative changes in the cerebral cortex involving the frontal, lateral temporal, parietal and occipital areas and in the cortical white …
REFLEXOLOGY, ALZHEIMER’S DISEASE, AND SLEEP A CASE …
The purpose of this case study was to explore the effects of reflexology on the sleep pattern and morning mood, of an 87-year-old elderly woman diagnosed with Alzheimer’s disease.
Case of early-onset Alzheimer s disease with atypical …
Short- term memory decline is the typical clinical manifestation of Alzheimer’s disease (AD). However, early- onset AD usually has atypical symptoms and may get misdiagnosed. In the …
AN AYURVEDIC APPROACH TO ALZHEIMER’S DISEASE – A …
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with major clinical hallmarks of memory loss, dementia, and cognitive impairment, comprising about 50-70% of dementias. …
A Case Study in Alzheimer’s Disease - Learning U
A Case Study in Alzheimer’s Disease A 69-year-old woman presents with symptoms of forgetfulness that worsen over time. Now the doctor must decide when a diagnosis of …
Physiotherapy for Alzheimer s Disease: A Case Report
The case study involves an 84-year-old woman displaying symptoms of Alzheimer’s disease requiring physiotherapy rehabilitation. Assessment reveals joint pain, abnormal gait, respiratory
Life quality and the self: A person-centered case study of …
The Person-Centered Approach (PCA) in Alzheimer’s allows a focus on all aspects that the disorder influences, thus all aspects of the self, in order to improve the quality of life (QOL) of …
A Review Article on Alzheimer Disease Case Study - ijrpr.com
Alzheimer disease is the neurodegenerative disorder. It is the sensible type of dementia. Alzheimer disease is discovered by Dr. Alois Alzheimer. In Alzheimer disease condition …
Ayurvedic Management of Alzheimer’s Disease – A single …
By 2050, over 75% of cases of Alzheimer’s disease and related dementias (ADRD) are expected to occur in low-and middle-income countries. In Ayurveda, the chapters Unmada, Apasmara, …
Early onset Alzheimer’s disease – a case study - ResearchGate
The article presents the case of a 33-year-old patient hospitalized in the Department of Neurology in Zabrze, with cognitive dysfunction, speech disorders and features of Parkinson’s...
Assessment and Management of Behavioral Symptoms in …
Case Study: Mrs. Harold Mrs. Eva Harold, a 78-year-old female, has been a resident of ABC Assisted Living for about two years. Her husband initially admitted her because of Alzheimer’s …
Case Study # 25 Alzheimer’s Disease
Alzheimer’s Disease “the most common form of dementia, characterized by formation of amyloid plaques in the brain and neurofibrillary tangles within neurons” (Nelms 610)
A Case Study of Cognitive – Educational Support for Elderly
This article is non-clinical, ethno-educational case study of individual, cognitive-educational, home-based support, conducted for 30 months by undergraduate female student for female …
